Lunai Bioworks Inc. Income Statement
LNAI|4 years of annual SEC 10-K data (FY2011-FY2017)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
Lunai Bioworks Inc. reported $42,769 in revenue and $2M in net loss for FY2017. Revenue has grown at a 9.3% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2014 | FY2011 |
|---|---|---|---|---|
| Revenue | $42.8K | $42.8K | $32.8K | $0 |
| Cost of Revenue | $5.3K | $295.7K | $109.3K | - |
| Gross Profit | $37.5K | -$295.7K | -$76.5K | - |
| SG&A Expense | $1.2M | $1.6M | $1.2M | $38.7K |
| R&D Expense | $804.2K | $1.6M | - | - |
| Operating Income | -$2.1M | -$2.4M | -$1.7M | - |
| Interest Expense | - | $84.5K | $652.7K | - |
| Income Tax | -$462.8K | -$177.5K | -$177.5K | $0 |
| Net Income | -$1.7M | -$2.4M | -$2.1M | -$38.7K |
| EPS (Diluted) | -$0.18 | -$0.32 | -$0.40 | $0.00 |
| Shares Outstanding | 9.5M | 9.5M | 6.0M | 0 |
| Gross Margin | 87.7% | -691.3% | -233.6% | - |
| Operating Margin | -4959.0% | -5679.9% | -5306.9% | - |
| Profit Margin | -4057.2% | -5543.5% | -6553.2% | - |